PainReform Ltd. (PRFX) Financials
PRFX Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-12-31 | 9.9 million | 2.7 million |
| 2023-09-30 | 10.9 million | 2.2 million |
| 2023-06-30 | 8.3 million | 1.3 million |
| 2023-03-31 | 10.4 million | 1.5 million |
PRFX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-12-31 | -1.5 million | 181000 |
| 2023-09-30 | -1.2 million | 182000 |
| 2023-06-30 | -2.0 million | 261000 |
| 2023-03-31 | -2.0 million | 180000 |
PRFX Net Income
No data available :(
PRFX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-12-31 | 8.0 million | - | 86000 |
| 2023-09-30 | 8.6 million | - | 94000 |
| 2023-06-30 | 6.2 million | - | - |
| 2023-03-31 | 8.1 million | - | - |
PRFX Shares Outstanding
PRFX Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-12-31 | 936 | 2.7 million | 818000 | 6000 |
| 2023-09-30 | 8000 | 589000 | 763000 | - |
| 2023-06-30 | - | 1.2 million | 1.0 million | - |
| 2023-03-31 | - | 1.5 million | 962000 | - |
PRFX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-12-31 | - | 6000 |
| 2023-09-30 | - | 3000 |
| 2023-06-30 | - | 4000 |
| 2023-03-31 | - | 2000 |
PRFX
Price: $0.82
52 week price:
Earnings Per Share: -7.14 USD
P/E Ratio: -0.30
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 9700
Market Capitalization: 2.9 million